SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-232444
Filing Date
2023-09-11
Accepted
2023-09-11 16:01:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d546529d424b3.htm 424B3 206771
2 GRAPHIC g546529g34k18.jpg GRAPHIC 35289
  Complete submission text file 0001193125-23-232444.txt   252481
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274264 | Film No.: 231247725
SIC: 2836 Biological Products, (No Diagnostic Substances)